Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Argen-X N.V. (Argenx). (8/11/14). "Press Release: Argen-X Raises Additional €1.8 million via Exercise of Over-allotment Option and Announces the End of the Stabilization Period in Relation to Its Initial Public Offering [Not for United States, Australia,

Region Region Brussels
  Country Belgium
Organisations Organisation Argen-X N.V. (Argenx) (Euronext + Nasdaq: ARGX)
  Group Argen-X (Argenx) (Group)
  Organisation 2 Euronext Brussels
  Group Euronext (Group)
Products Product SIMPLE Antibody™ discovery platform
  Product 2 investment banking
Index term Index term Argen-X–SEVERAL: investment, 201406–201408 IPO €41.8m 4.7m+0.2m shares at €8.5/shares at Euronext Brussels
Persons Person Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G)
  Person 2 Swallow, Mark (Huntsworth 201101 Citigate Dewe Rogerson London)
     


   
Record changed: 2017-04-17

Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for Argen-X (Argenx) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top